BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24045583)

  • 1. Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery.
    Reisen F; Zhang X; Gabriel D; Selzer P
    J Biomol Screen; 2013 Dec; 18(10):1284-97. PubMed ID: 24045583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
    Azegrouz H; Karemore G; Torres A; Alaíz CM; Gonzalez AM; Nevado P; Salmerón A; Pellinen T; del Pozo MA; Dorronsoro JR; Montoya MC
    J Biomol Screen; 2013 Dec; 18(10):1270-83. PubMed ID: 24045580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking phenotypes and modes of action through high-content screen fingerprints.
    Reisen F; Sauty de Chalon A; Pfeifer M; Zhang X; Gabriel D; Selzer P
    Assay Drug Dev Technol; 2015 Sep; 13(7):415-27. PubMed ID: 26258308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and visualization of diverse cellular phenotypic responses in primary high-content screening.
    Kümmel A; Selzer P; Siebert D; Schmidt I; Reinhardt J; Götte M; Ibig-Rehm Y; Parker CN; Gabriel D
    J Biomol Screen; 2012 Jul; 17(6):843-9. PubMed ID: 22396475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation.
    Isherwood BJ; Walls RE; Roberts ME; Houslay TM; Brave SR; Barry ST; Carragher NO
    J Biomol Screen; 2013 Dec; 18(10):1246-59. PubMed ID: 24108119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCS-Neurons: identifying phenotypic changes in multi-neuron images upon drug treatments of high-content screening.
    Charoenkwan P; Hwang E; Cutler RW; Lee HC; Ko LW; Huang HL; Ho SY
    BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S12. PubMed ID: 24564437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCS road: an enterprise system for integrated HCS data management and analysis.
    Jackson D; Lenard M; Zelensky A; Shaikh M; Scharpf JV; Shaginaw R; Nawade M; Agler M; Cloutier NJ; Fennell M; Guo Q; Wardwell-Swanson J; Zhao D; Zhu Y; Miller C; Gill J
    J Biomol Screen; 2010 Aug; 15(7):882-91. PubMed ID: 20639503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High content screening: seeing is believing.
    Zanella F; Lorens JB; Link W
    Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of image segmentation on high-content screening data quality for SK-BR-3 cells.
    Hill AA; LaPan P; Li Y; Haney S
    BMC Bioinformatics; 2007 Sep; 8():340. PubMed ID: 17868449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workflow-based software environment for large-scale biological experiments.
    Kozak K; Bakos G; Hoff A; Bennett E; Dunican D; Davies A; Kelleher D; Long A; Csucs G
    J Biomol Screen; 2010 Aug; 15(7):892-9. PubMed ID: 20625182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of belief theory to similarity data fusion for use in analog searching and lead hopping.
    Muchmore SW; Debe DA; Metz JT; Brown SP; Martin YC; Hajduk PJ
    J Chem Inf Model; 2008 May; 48(5):941-8. PubMed ID: 18416545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multivariate Computational Method to Analyze High-Content RNAi Screening Data.
    Rameseder J; Krismer K; Dayma Y; Ehrenberger T; Hwang MK; Airoldi EM; Floyd SR; Yaffe MB
    J Biomol Screen; 2015 Sep; 20(8):985-97. PubMed ID: 25918037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of Multidimensional Data in the Analysis of Ultra-High-Throughput High Content Phenotypic Screens.
    Wardwell-Swanson J; Hu Y
    Methods Mol Biol; 2018; 1683():267-290. PubMed ID: 29082498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A personal perspective on high-content screening (HCS): from the beginning.
    Taylor DL
    J Biomol Screen; 2010 Aug; 15(7):720-5. PubMed ID: 20639498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image analysis benchmarking methods for high-content screen design.
    Fuller CJ; Straight AF
    J Microsc; 2010 May; 238(2):145-61. PubMed ID: 20529062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of cell phenotypes in HCS: limitations and advantages.
    Gasparri F
    Expert Opin Drug Discov; 2009 Jun; 4(6):643-57. PubMed ID: 23489157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computerized cellular imaging system for high content analysis in Monastrol suppressor screens.
    Zhou X; Cao X; Perlman Z; Wong ST
    J Biomed Inform; 2006 Apr; 39(2):115-25. PubMed ID: 16011909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.